Biomerica (BMRA) Non Operating Income (2012 - 2026)
Biomerica (BMRA) reported Non Operating Income of -$6000.0 for Q1 2026, down 113.95% on a YoY basis from $43000.0 in Q1 2025, and down 110.34% sequentially from $58000.0 in Q4 2025.
Biomerica (BMRA) Non Operating Income (2012 - 2026) Analysis & Trends
Biomerica (BMRA) has 15 years of Non Operating Income data on file, last reported at -$6000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 113.95% year-over-year to -$6000.0; the trailing twelve-month figure through Feb 2026 stood at $1.2 million (up 374.31% YoY), and the FY2025 full-year result was $165000.0, down 61.72% from the prior year.
- Non Operating Income retreated to -$6000.0 in Q1 2026, from $58000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.1 million in Q3 2025 to a low of -$6000.0 in Q1 2026.
- A 5-year average of $127001.9 and a median of $56000.0 in 2024 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income surged 439185.71% in 2023 and slumped 113.95% in 2026, its largest moves.
- Tracing BMRA's Non Operating Income over 5 years: stood at $41000.0 in 2022, then jumped by 165.85% to $109000.0 in 2023, then tumbled by 63.3% to $40000.0 in 2024, then jumped by 45.0% to $58000.0 in 2025, then sank by 110.34% to -$6000.0 in 2026.
- Business Quant data shows BMRA's Non Operating Income at -$6000.0 in Q1 2026, $58000.0 in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | -6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -6,000.00 |
| Nov 30, 2025 | 58,000.00 |
| Aug 31, 2025 | 1.12 Mn |
| May 31, 2025 | 25,000.00 |
| Feb 28, 2025 | 43,000.00 |
| Nov 30, 2024 | 40,000.00 |
| Aug 31, 2024 | 56,000.00 |
| May 31, 2024 | 114,000.00 |
| Feb 29, 2024 | 86,000.00 |
| Nov 30, 2023 | 109,000.00 |
| Aug 31, 2023 | 123,000.00 |
| May 31, 2023 | 57,000.00 |
| Feb 28, 2023 | 36,000.00 |
| Nov 30, 2022 | 41,000.00 |
| Aug 31, 2022 | 28.00 |
| Aug 31, 2021 | 6,805.00 |
| May 31, 2021 | 12,735.00 |
| Feb 28, 2021 | 37,687.00 |
| Nov 30, 2020 | 7,983.00 |
| Aug 31, 2020 | 8,091.00 |